Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FL2A2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $164,083
Award facts
- Contract value 100% obligated
- $164,083.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $164,083.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. The award, announced on September 16, 2025, with an ultimate completion date of October 7, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500 million through November 2026, which provides the agency with a comprehensive pharmaceutical supply vehicle for medications and medical consumables supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical distribution network, leveraging its woman-owned small business status to compete effectively for federal contracts without specific set-aside requirements. As a registered SAM.gov vendor since 2001, the company specializes in distributing branded and generic prescription drugs, biologics, and medical supplies to military and federal healthcare systems. This particular delivery order for Keytruda, a branded oncology treatment, exemplifies the company's portfolio of high-value pharmaceutical products delivered to support the medical needs of Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FL2A2?
SPE2DB25FL2A2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FL2A2 worth?
The government has obligated $164,083 on SPE2DB25FL2A2.
Is contract SPE2DB25FL2A2 an order under another contract?
Yes. SPE2DB25FL2A2 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL2A2 competed?
The extent of competition for SPE2DB25FL2A2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award